WASHINGTON, Sept. 20, 2016 -- Media accreditation now is open, with new launch dates, for the next NASA-contracted cargo resupply flight launching from Virginia to the International Space Station.
Orbital ATK is targeting no earlier than Oct. 9-13 for the launch of its Cygnus spacecraft on an Antares rocket from the Mid-Atlantic Regional Spaceport's Pad-0A at NASA's Wallops Flight Facility in Wallops Island, Virginia. A more specific date will be identified after completion of final operational milestones and technical reviews. Launch times range from 10:47 p.m. EDT Sunday, Oct. 9 to 9:13 p.m. Thursday, Oct. 13.
International media without U.S. citizenship must have previously applied for credentials to cover the prelaunch and launch activities at Wallops. The application deadline is Friday, Sept. 30 for media who are U.S. citizens. Media should send their accreditation request to Keith Koehler at [email protected]. For questions about accreditation or additional information, contact Koehler by email or at 757-824-1579.
This will be the sixth planned cargo resupply mission by Orbital ATK under NASA's Commercial Resupply Services contract with the company and the fourth launch from Virginia. Cargo resupply by U.S. companies enables a national capability to deliver critical science research to the space station, significantly increasing NASA's ability to conduct new science investigations aboard the world's only microgravity laboratory.
Get more information about Orbital ATK, its Antares rocket and the Cygnus cargo spacecraft at:


NASA Faces Major Workforce Reduction as 20% of Employees Prepare to Leave
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
FDA Lifts REMS Requirement for CAR-T Cell Cancer Therapies
Neuralink Expands Brain Implant Trials with 12 Global Patients
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay
Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Tabletop particle accelerator could transform medicine and materials science
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 



